MNOV
MEDICINOVA INC
NASDAQ · Healthcare · Biotechnology · US
$1.45
+2.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 18.00x
- P/S forward
- 98.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.91x
- Price / sales
- 77.54x
- Price / cash flow
- -0.04x
Enterprise value
- Enterprise value
- $46.1M
- EV / sales
- 50.05x
- EV / EBITDA
- -4.21x
- EV / EBIT
- -3.89x
- Market cap
- $71.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026